MMT Home Banner

Driven by evidence
Backed with a guarantee

Blood culture results you can trust

UH Cost-Benefit Released

Newly Released: Cost-Benefit Analysis of Steripath

A University of Houston study concludes hospitals can save up to $367 per blood culture after adopting Steripath.


A Partnership Inspired by Evidence

We are pleased to announce our partnership with the Center for Phlebotomy Education. Discover new evidence-based education, training and earn CEU credit.

Vizient Innovation Contract Background

Vizient Innovative Technology Contract

Steripath Gen2 is designated an Innovative Technology, offering unique benefits over other products available in the market today.

SteriPath Gen2 showing diverted contaminants
Steripath Logo

Partnering with you to eliminate blood culture contamination

The Steripath® Gen2 Initial Specimen Diversion Device (ISDD®) has been clinically proven to virtually eliminate preventable blood culture contamination and false-positive results for bloodstream infections and sepsis.

Clinically Proven, Guaranteed Results.

Lee Health Improves Sepsis Testing Accuracy

Lee Health clinicians reported an 83% reduction in false positive diagnostic results for bloodstream infections like sepsis, following the adoption of Steripath across the health system’s four emergency departments.

UNMC Clinical Trials

Used by reputable hospitals around the country and proven in countless clinical trials– Steripath has been clinically proven to sustain a blood culture rate of 0.2% and a reduction in false positives by 92%.

MUSC Health Achieves Unprecedented Results

The Medical University of South Carolina achieved a nearly four-fold decrease in contaminated blood cultures in their Emergency Department, sustained over 20 months. They discuss their experience with Steripath and the impact that improved sepsis diagnostic accuracy has on patient safety.


CE Course by Center of Phlebotomy Education

Earn Credits Today
Dennis J. Ernst MT (ASCP), NCPT (NCCT) | Credit Hours: 1.0

Our Vision

Through our focus on specimen integrity and testing accuracy, we aim to:

patient misdiagnoses and ensuing mistreatments
lives at minimum
in direct cost savings for our hospital customers

The Scientist
Behind Steripath

Transforming Medical Care for Providers and Patients

We are focused on improving critical processes and technologies to deliver unprecedented efficiency, effectiveness, and optimal patient outcomes.  With over 42 patents in our portfolio, we’ll keep innovating until we change the status quo.